Inspire Medical Systems/$INSP
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Inspire Medical Systems
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Ticker
$INSP
Sector
Primary listing
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
1,246
ISIN
US4577301090
Website
INSP Metrics
BasicAdvanced
$3.8B
59.87
$2.17
1.39
-
Price and volume
Market cap
$3.8B
Beta
1.39
52-week high
$216.01
52-week low
$123.00
Average daily volume
535K
Financial strength
Current ratio
9.007
Quick ratio
7.276
Long term debt to equity
4.953
Total debt to equity
4.953
Interest coverage (TTM)
2,264.36%
Profitability
EBITDA (TTM)
58.571
Gross margin (TTM)
84.65%
Net profit margin (TTM)
7.92%
Operating margin (TTM)
5.93%
Effective tax rate (TTM)
7.59%
Revenue per employee (TTM)
$670,000
Management effectiveness
Return on assets (TTM)
4.40%
Return on equity (TTM)
10.86%
Valuation
Price to earnings (TTM)
59.869
Price to revenue (TTM)
4.599
Price to book
6.01
Price to tangible book (TTM)
6.01
Price to free cash flow (TTM)
48.998
Free cash flow yield (TTM)
2.04%
Free cash flow per share (TTM)
264.73%
Growth
Revenue change (TTM)
27.11%
Earnings per share change (TTM)
-505.07%
3-year revenue growth (CAGR)
47.38%
3-year earnings per share growth (CAGR)
11.71%
What the Analysts think about INSP
Analyst ratings (Buy, Hold, Sell) for Inspire Medical Systems stock.
Bulls say / Bears say
Inspire Medical Systems reported a 25% year-over-year revenue increase in Q4 2024, reaching $239.7 million, indicating strong market demand and effective sales strategies. (investors.inspiresleep.com)
The company achieved a gross margin of 85.0% in Q4 2024, reflecting efficient cost management and a robust pricing strategy. (investors.inspiresleep.com)
Inspire Medical Systems activated 66 new U.S. centers in Q3 2024, expanding its reach and potential patient base. (investors.inspiresleep.com)
Operating expenses increased to $171.8 million in Q4 2024, an 11% rise from the previous year, which could pressure profitability if revenue growth slows. (investors.inspiresleep.com)
The company's net income margin remains relatively low, with a net income of $35.2 million on $239.7 million in revenue for Q4 2024, suggesting limited profitability. (investors.inspiresleep.com)
Despite revenue growth, the company faces challenges in managing operating expenses, which could impact future profitability. (dcfmodeling.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
INSP Financial Performance
Revenues and expenses
INSP Earnings Performance
Company profitability
INSP News
AllArticlesVideos
Inspire Medical Systems, Inc. to Present at the Truist Securities MedTech Conference
GlobeNewsWire·3 weeks ago
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
GlobeNewsWire·4 weeks ago
Dr. Jose Jacob Scholarship for Future Doctors Opens Nationwide: A Timely Opportunity to Inspire Medical Students to Address Real-World Healthcare Challenges
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Inspire Medical Systems stock?
Inspire Medical Systems (INSP) has a market cap of $3.8B as of June 27, 2025.
What is the P/E ratio for Inspire Medical Systems stock?
The price to earnings (P/E) ratio for Inspire Medical Systems (INSP) stock is 59.87 as of June 27, 2025.
Does Inspire Medical Systems stock pay dividends?
No, Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders as of June 27, 2025.
When is the next Inspire Medical Systems dividend payment date?
Inspire Medical Systems (INSP) stock does not pay dividends to its shareholders.
What is the beta indicator for Inspire Medical Systems?
Inspire Medical Systems (INSP) has a beta rating of 1.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.